Puri Parul, Girotra Siaa, Ghosh Arpita
The George Institute for Global Health, New Delhi, India.
The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
J Multimorb Comorb. 2025 Jul 4;15:26335565251355837. doi: 10.1177/26335565251355837. eCollection 2025 Jan-Dec.
Demographic and epidemiological shifts have led to people living with coexisting health issues, known as 'multimorbidity'. Given India's aging population, rising noncommunicable disease burden, chronic infections, fragmented healthcare, and reliance on specialist care, a scoping review is needed to understand the extent and nature of research on multimorbidity in India.
A comprehensive search was conducted across PubMed, Cochrane, and Embase for studies focused on multimorbidity, with information specifically from India. Two reviewers independently screened the results and extracted information on definitions, including use of cut-offs or a minimum number of conditions, data and methods, patterns, risk factors and outcomes. Results were synthesized using descriptive statistics and narrative synthesis.
Of 9954 identified studies, 100 were included in the final synthesis. Of these, 62 were secondary analyses, 35 collected primary data, and 3 used administrative data. Most studies defined multimorbidity as two or more chronic or long-term conditions but did not specify whether long-term infections or mental health conditions were included. The number of conditions varied between 4 and 22. Circulatory, endocrine-nutritional-metabolic, and respiratory diseases were most frequently included. Beyond simple disease counts, combinations were reported in 15 studies. Healthcare utilization, out-of-pocket expenditure, and quality of life were commonly studied, mostly using cross-sectional designs.
A standardised panel of conditions with clear definitions is needed for measuring multimorbidity. Conditions should be ascertained through a combination of self-report, physical examinations, and laboratory investigations. Additionally, longitudinal studies focused on multimorbidity, and its outcomes are needed to strengthen evidence base in India.
人口结构和流行病学的变化导致人们同时患有多种健康问题,即“多重疾病”。鉴于印度人口老龄化、非传染性疾病负担不断增加、慢性感染、医疗保健碎片化以及对专科护理的依赖,需要进行一项范围综述,以了解印度多重疾病研究的范围和性质。
在PubMed、Cochrane和Embase上进行了全面检索,以查找专注于多重疾病的研究,特别是来自印度的信息。两名评审员独立筛选结果,并提取有关定义的信息,包括临界值的使用或疾病的最小数量、数据和方法、模式、风险因素和结果。使用描述性统计和叙述性综合对结果进行综合分析。
在9954项已识别的研究中,100项被纳入最终综合分析。其中,62项为二次分析,35项收集了原始数据,3项使用了行政数据。大多数研究将多重疾病定义为两种或更多种慢性或长期疾病,但未具体说明是否包括长期感染或精神健康疾病。疾病数量在4至22种之间。循环系统、内分泌-营养-代谢和呼吸系统疾病最常被纳入。除了简单的疾病计数外,15项研究报告了疾病组合情况。医疗保健利用、自付费用和生活质量是常见的研究内容,大多采用横断面设计。
需要一个有明确定义的标准化疾病清单来衡量多重疾病。应通过自我报告、体格检查和实验室检查相结合的方式确定疾病情况。此外,需要开展关注多重疾病及其结果的纵向研究,以加强印度的证据基础。